Skip to main content
Erschienen in: Heart Failure Reviews 1/2020

08.11.2019

The role of the kidney in acute and chronic heart failure

verfasst von: Gaetano Ruocco, Alberto Palazzuoli, Jozine M. ter Maaten

Erschienen in: Heart Failure Reviews | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Renal dysfunction affects approximately 30 to 50% of heart failure (HF) patients. The unfavourable relationship between heart and kidney dysfunction contributes to worse outcomes through several mechanisms such as inflammation, oxidative stress, impaired hydrosaline homeostasis, and diuretic resistance. Renal dysfunction not only carries important prognostic value both in acute and in chronic HF, but also is a potential precipitating factor after the first diagnosis. Because renal dysfunction encompasses different etiologies, a better understanding of its definition, incidence, and pathophysiology provides additional information. Although old and novel available biomarkers for the detection of renal dysfunction have been recently proposed, there is no general consensus regarding the terminology and definition of renal dysfunction in HF. Due to some specific pathophysiological mechanisms, renal impairment seems to be different on an individual patient level and, recognizing it in acute and chronic settings, could be useful to optimize decongestive treatment. For these reasons, in this review, we aim to describe and evaluate different phenotypes of renal dysfunction in acute and chronic HF and the possible management in these settings.

Key messages

• Chronic kidney dysfunction and worsening renal function are highly prevalent in acute heart failure and chronic heart failure and associated with poor outcomes.
• This association is modified by the context in which it occurs, i.e. worsening renal function in the context of adequate decongestion in acute heart failure, or worsening renal function after initiation of neurohormonal blockers in chronic heart failure.
• Future research should be aimed at elucidating the mechanisms involved in these differenct contexts, as well as alternative treatment approaches in the case of true worsening renal function.
Literatur
1.
Zurück zum Zitat Heywood JT, Fonarow GC (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE Database. J Card Fail 13:422–430PubMed Heywood JT, Fonarow GC (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE Database. J Card Fail 13:422–430PubMed
2.
Zurück zum Zitat Klein L, Massie BM, Leimberger JD et al (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict post discharge survival. Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 1:25–33PubMed Klein L, Massie BM, Leimberger JD et al (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict post discharge survival. Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 1:25–33PubMed
3.
Zurück zum Zitat Smith GL, Lichtman JH, Bracken MB et al (2006) Renal impairment and outcomes in heart failure systematic review and meta-analysis. J Am Coll Cardiol 47:1987–1996PubMed Smith GL, Lichtman JH, Bracken MB et al (2006) Renal impairment and outcomes in heart failure systematic review and meta-analysis. J Am Coll Cardiol 47:1987–1996PubMed
4.
Zurück zum Zitat Damman K, Tang WH, Testani JM, McMurray JJ (2014) Terminology and definition of changes renal function in heart failure. Eur Heart J 35:3413–3416PubMedPubMedCentral Damman K, Tang WH, Testani JM, McMurray JJ (2014) Terminology and definition of changes renal function in heart failure. Eur Heart J 35:3413–3416PubMedPubMedCentral
6.
Zurück zum Zitat Savarese G, Xu H, Trevisan M et al (2019) Incidence, predictors, and outcome associations of dyskalemia in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail 7:65–76PubMed Savarese G, Xu H, Trevisan M et al (2019) Incidence, predictors, and outcome associations of dyskalemia in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail 7:65–76PubMed
7.
Zurück zum Zitat Testani JM, Hanberg JS, Arroyo JP et al (2016) Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail 18:660–668PubMed Testani JM, Hanberg JS, Arroyo JP et al (2016) Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail 18:660–668PubMed
8.
Zurück zum Zitat Palazzuoli A, Ruocco G (2018) Heart-kidney interactions in cardiorenal syndrome type 1. Adv Chronic Kidney Dis 25:408–417PubMed Palazzuoli A, Ruocco G (2018) Heart-kidney interactions in cardiorenal syndrome type 1. Adv Chronic Kidney Dis 25:408–417PubMed
9.
Zurück zum Zitat Palazzuoli A, Lombardi C, Ruocco G et al (2016) Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? Eur Heart J Acute Cardiovasc Care 5:534–548PubMed Palazzuoli A, Lombardi C, Ruocco G et al (2016) Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? Eur Heart J Acute Cardiovasc Care 5:534–548PubMed
10.
Zurück zum Zitat Ronco C, Cicoira MA, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60:1031–1042PubMed Ronco C, Cicoira MA, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60:1031–1042PubMed
11.
Zurück zum Zitat Saltzman HE, Sharma K, Mather PJ, Rubin S, Adams S, Whellan DJ (2007) Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev 12:37–47PubMed Saltzman HE, Sharma K, Mather PJ, Rubin S, Adams S, Whellan DJ (2007) Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev 12:37–47PubMed
12.
Zurück zum Zitat Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE (2011) Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail 13:877–884PubMedPubMedCentral Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE (2011) Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail 13:877–884PubMedPubMedCentral
13.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589PubMedPubMedCentral Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589PubMedPubMedCentral
14.
Zurück zum Zitat Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–585PubMed Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–585PubMed
15.
Zurück zum Zitat Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M (2008) Fluid overload in acute heart failure-redistribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165–169PubMed Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M (2008) Fluid overload in acute heart failure-redistribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165–169PubMed
16.
Zurück zum Zitat Mullens W, Verbrugge FH, Nijst P, Tang WHW (2017) Renal sodium avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J 38:1872–1882PubMed Mullens W, Verbrugge FH, Nijst P, Tang WHW (2017) Renal sodium avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J 38:1872–1882PubMed
17.
Zurück zum Zitat Verbrugge FH, Dupont M, Steels P et al (2014) The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’. Eur J Heart Fail 16:133–142PubMed Verbrugge FH, Dupont M, Steels P et al (2014) The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’. Eur J Heart Fail 16:133–142PubMed
18.
Zurück zum Zitat Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51:300–306PubMed Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51:300–306PubMed
19.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH (2008) Prompt reduction in intraabdominal pressure following large volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14:508–514PubMed Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH (2008) Prompt reduction in intraabdominal pressure following large volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14:508–514PubMed
20.
Zurück zum Zitat Jessup M, Costanzo MR (2009) The cardiorenal syndrome do we need a change of strategy of a change of tactics? J Am Coll Cardiol 53:597–599PubMed Jessup M, Costanzo MR (2009) The cardiorenal syndrome do we need a change of strategy of a change of tactics? J Am Coll Cardiol 53:597–599PubMed
21.
Zurück zum Zitat Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMed Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMed
22.
Zurück zum Zitat Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36:S75–S88PubMed Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36:S75–S88PubMed
23.
Zurück zum Zitat Cruz DN, Gheorghiade M, Palazzuoli A, Ronco C, Bagshaw SM (2011) Epidemiology and outcome of the cardio-renal syndrome. Heart Fail Rev 16:531–542PubMed Cruz DN, Gheorghiade M, Palazzuoli A, Ronco C, Bagshaw SM (2011) Epidemiology and outcome of the cardio-renal syndrome. Heart Fail Rev 16:531–542PubMed
24.
Zurück zum Zitat Damman K, Valente MA, Voors AA et al (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35:455–469PubMed Damman K, Valente MA, Voors AA et al (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35:455–469PubMed
25.
Zurück zum Zitat Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274PubMed Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274PubMed
26.
Zurück zum Zitat Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188–195PubMed Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188–195PubMed
27.
Zurück zum Zitat Voors AA, Dittrich HC, Massie BM et al (2011) Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol 57:1899–1907PubMed Voors AA, Dittrich HC, Massie BM et al (2011) Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol 57:1899–1907PubMed
28.
Zurück zum Zitat Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B, on behalf of the POSH Investigators (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27:1216–1222PubMed Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B, on behalf of the POSH Investigators (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27:1216–1222PubMed
29.
Zurück zum Zitat Krumholz HM, Chen Y, Vaccarino V et al (2000) Correlates and impact on outcomes of worsening renal function in patients >=65 years of age with heart failure. Am J Cardiol 85:1110–1113PubMed Krumholz HM, Chen Y, Vaccarino V et al (2000) Correlates and impact on outcomes of worsening renal function in patients >=65 years of age with heart failure. Am J Cardiol 85:1110–1113PubMed
30.
Zurück zum Zitat Gottlieb SS, Abraham W, Butler J et al (2002) The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8:136–141PubMed Gottlieb SS, Abraham W, Butler J et al (2002) The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8:136–141PubMed
31.
Zurück zum Zitat Metra M, Cotter G (2013) Davison BA et al; RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61:196–206PubMed Metra M, Cotter G (2013) Davison BA et al; RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61:196–206PubMed
32.
Zurück zum Zitat Waikar SS, Bonventre JV (2009) Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20:672–679PubMedPubMedCentral Waikar SS, Bonventre JV (2009) Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20:672–679PubMedPubMedCentral
33.
Zurück zum Zitat Ather S, Bavishi C, McCauley MD et al (2013) Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol 167:1912–1917PubMed Ather S, Bavishi C, McCauley MD et al (2013) Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol 167:1912–1917PubMed
34.
Zurück zum Zitat Van Deursen VM, Hernandez AF, Stebbins A et al (2014) Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation. 130:958–965PubMed Van Deursen VM, Hernandez AF, Stebbins A et al (2014) Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation. 130:958–965PubMed
35.
Zurück zum Zitat Testani JM, McCauley BD, Chen J, Coca SG, Cappola TP, Kimmel SE (2011) Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail 17:993–1000PubMedPubMedCentral Testani JM, McCauley BD, Chen J, Coca SG, Cappola TP, Kimmel SE (2011) Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail 17:993–1000PubMedPubMedCentral
36.
Zurück zum Zitat Damman K, Jaarsma T, Voors AA et al (2009) Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 11:847–854PubMed Damman K, Jaarsma T, Voors AA et al (2009) Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 11:847–854PubMed
37.
Zurück zum Zitat Breidthardt T, Sabti Z, Ziller R et al (2017) Diagnostic and prognostic value of cystatin C in acute heart failure. Clin Biochem 50:1007–1013PubMed Breidthardt T, Sabti Z, Ziller R et al (2017) Diagnostic and prognostic value of cystatin C in acute heart failure. Clin Biochem 50:1007–1013PubMed
38.
Zurück zum Zitat Lemoine S, Panaye M, Pelletier C et al (2016) Cystatin C-creatinine based glomerular filtration rate equation in obese chronic kidney disease patients: impact of deindexation and gender. Am J Nephrol 44:63–70PubMed Lemoine S, Panaye M, Pelletier C et al (2016) Cystatin C-creatinine based glomerular filtration rate equation in obese chronic kidney disease patients: impact of deindexation and gender. Am J Nephrol 44:63–70PubMed
39.
Zurück zum Zitat Kervella D, Lemoine S, Sens F et al (2017) Cystatin C versus creatinine for gfr estimation in CKD due to heart failure. Am J Kidney Dis 69:321–323PubMed Kervella D, Lemoine S, Sens F et al (2017) Cystatin C versus creatinine for gfr estimation in CKD due to heart failure. Am J Kidney Dis 69:321–323PubMed
40.
Zurück zum Zitat Kazory A (2010) Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 106:694–700PubMed Kazory A (2010) Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 106:694–700PubMed
41.
Zurück zum Zitat Palazzuoli A, Ruocco G, Pellicori P et al (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. Int J Cardiol 276:198–203PubMed Palazzuoli A, Ruocco G, Pellicori P et al (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. Int J Cardiol 276:198–203PubMed
42.
Zurück zum Zitat Ruocco G, Pellegrini M, De Gori C, Franci B, Nuti R, Palazzuoli A (2016) The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure. J Cardiovasc Med (Hagerstown) 17:818–827 Ruocco G, Pellegrini M, De Gori C, Franci B, Nuti R, Palazzuoli A (2016) The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure. J Cardiovasc Med (Hagerstown) 17:818–827
43.
Zurück zum Zitat Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466–473PubMed Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466–473PubMed
44.
Zurück zum Zitat Matsue Y, van der Meer P, Damman K et al (2017 Mar) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart. 103:407–413PubMed Matsue Y, van der Meer P, Damman K et al (2017 Mar) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart. 103:407–413PubMed
45.
Zurück zum Zitat Brisco MA, Coca SG, Chen J et al (2013) Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail 6:233–239PubMedPubMedCentral Brisco MA, Coca SG, Chen J et al (2013) Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail 6:233–239PubMedPubMedCentral
46.
Zurück zum Zitat Testani JM, Damman K, Brisco MA et al (2014) A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failure. J Card Fail 20:912–919PubMedPubMedCentral Testani JM, Damman K, Brisco MA et al (2014) A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failure. J Card Fail 20:912–919PubMedPubMedCentral
47.
Zurück zum Zitat Cruz D, Goh CY, Palazzuoli A et al (2011) Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Fail Rev 16:545–551PubMed Cruz D, Goh CY, Palazzuoli A et al (2011) Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Fail Rev 16:545–551PubMed
48.
Zurück zum Zitat Soni SS, Ronco C, Katz N, Cruz DN (2009) Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 28:165–174PubMed Soni SS, Ronco C, Katz N, Cruz DN (2009) Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 28:165–174PubMed
49.
Zurück zum Zitat Maisel AS, Wettersten N, van Veldhuisen DJ et al (2016) Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol 68:1420–1431PubMed Maisel AS, Wettersten N, van Veldhuisen DJ et al (2016) Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol 68:1420–1431PubMed
50.
Zurück zum Zitat Ruocco G, Nuti R, Giambelluca A et al (2017) The paradox of transient worsening renal function in patients with acute heart failure: the role of B-type natriuretic peptide and diuretic response. J Cardiovasc Med (Hagerstown) 18:851–858 Ruocco G, Nuti R, Giambelluca A et al (2017) The paradox of transient worsening renal function in patients with acute heart failure: the role of B-type natriuretic peptide and diuretic response. J Cardiovasc Med (Hagerstown) 18:851–858
51.
Zurück zum Zitat Fudim M, Loungani R, Doerfler SM et al (2018) Worsening renal function during decongestion among patients hospitalized for heart failure: findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial. Am Heart J 204:163–173PubMed Fudim M, Loungani R, Doerfler SM et al (2018) Worsening renal function during decongestion among patients hospitalized for heart failure: findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial. Am Heart J 204:163–173PubMed
52.
Zurück zum Zitat Metra M, Cotter G, Senger S et al (2018) Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion: a post hoc analysis of the PROTECT data. Circ Heart Fail 11:e004644PubMed Metra M, Cotter G, Senger S et al (2018) Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion: a post hoc analysis of the PROTECT data. Circ Heart Fail 11:e004644PubMed
53.
Zurück zum Zitat Blair JE, Pang PS, Schrier RW, EVEREST Investigators et al (2011) Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J 32:2563–2572PubMed Blair JE, Pang PS, Schrier RW, EVEREST Investigators et al (2011) Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J 32:2563–2572PubMed
54.
Zurück zum Zitat Aronson D, Burger AJ (2010) The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail 16:541–547PubMed Aronson D, Burger AJ (2010) The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail 16:541–547PubMed
55.
Zurück zum Zitat Palazzuoli A, Ruocco G, Ronco C, McCullough PA (2015) Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney. Crit Care 19:296PubMedPubMedCentral Palazzuoli A, Ruocco G, Ronco C, McCullough PA (2015) Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney. Crit Care 19:296PubMedPubMedCentral
57.
Zurück zum Zitat Núñez J, Garcia S, Núñez E et al (2017) Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited. Eur Heart J Acute Cardiovasc Care 6:430–440PubMed Núñez J, Garcia S, Núñez E et al (2017) Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited. Eur Heart J Acute Cardiovasc Care 6:430–440PubMed
58.
Zurück zum Zitat Brisco MA, Zile MR, Hanberg JS et al (2016) Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial. J Card Fail 22:753–760PubMedPubMedCentral Brisco MA, Zile MR, Hanberg JS et al (2016) Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial. J Card Fail 22:753–760PubMedPubMedCentral
59.
Zurück zum Zitat Boulos J, Darawsha W, Abassi ZA, Azzam ZS, Aronson D (2019) Treatment patterns of patients with acute heart failure who develop acute kidney injury. ESC Heart Fail 6:45–52PubMed Boulos J, Darawsha W, Abassi ZA, Azzam ZS, Aronson D (2019) Treatment patterns of patients with acute heart failure who develop acute kidney injury. ESC Heart Fail 6:45–52PubMed
60.
Zurück zum Zitat Mullens W, Damman K, Harjola VP et al (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137–155PubMed Mullens W, Damman K, Harjola VP et al (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137–155PubMed
61.
Zurück zum Zitat Kuriyama A, Urushidani S (2019) Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev 24:31–39PubMed Kuriyama A, Urushidani S (2019) Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev 24:31–39PubMed
62.
Zurück zum Zitat Felker GM, Lee KL, Bull DA, NHLBI Heart Failure Clinical Research Network et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805PubMedPubMedCentral Felker GM, Lee KL, Bull DA, NHLBI Heart Failure Clinical Research Network et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805PubMedPubMedCentral
63.
Zurück zum Zitat Palazzuoli A, Pellegrini M, Ruocco G et al (2014) Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care 18:R134PubMedPubMedCentral Palazzuoli A, Pellegrini M, Ruocco G et al (2014) Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care 18:R134PubMedPubMedCentral
64.
Zurück zum Zitat Verbrugge FH (2018) Editor's Choice-Diuretic resistance in acute heart failure. Eur Heart J Acute Cardiovasc Care 7:379–389PubMed Verbrugge FH (2018) Editor's Choice-Diuretic resistance in acute heart failure. Eur Heart J Acute Cardiovasc Care 7:379–389PubMed
65.
Zurück zum Zitat ter Maaten JM, Dunning AM, Valente MA et al (2015) Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J 170:313–321PubMed ter Maaten JM, Dunning AM, Valente MA et al (2015) Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J 170:313–321PubMed
66.
Zurück zum Zitat Valente MA, Voors AA, Damman K et al (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293PubMed Valente MA, Voors AA, Damman K et al (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293PubMed
67.
Zurück zum Zitat Mullens W, Verbrugge FH, Nijst P et al (2018) Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. Eur J Heart Fail 20:1591–1600PubMed Mullens W, Verbrugge FH, Nijst P et al (2018) Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. Eur J Heart Fail 20:1591–1600PubMed
68.
Zurück zum Zitat Moranville MP, Choi S, Hogg J, Anderson AS, Rich JD (2015) Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther 33:42–49PubMed Moranville MP, Choi S, Hogg J, Anderson AS, Rich JD (2015) Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther 33:42–49PubMed
69.
Zurück zum Zitat Brisco-Bacik MA, Ter Maaten JM, Houser SR et al (2018) Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis. J Am Heart Assoc 7:e009149PubMedPubMedCentral Brisco-Bacik MA, Ter Maaten JM, Houser SR et al (2018) Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis. J Am Heart Assoc 7:e009149PubMedPubMedCentral
70.
Zurück zum Zitat Bistola V, Simitsis P, Farmakis D et al (2018) Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin Res Cardiol 107:76–86PubMed Bistola V, Simitsis P, Farmakis D et al (2018) Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin Res Cardiol 107:76–86PubMed
71.
Zurück zum Zitat Verbrugge FH, Martens P, Ameloot K et al (2018) Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome. Acta Cardiol 27:1–8 Verbrugge FH, Martens P, Ameloot K et al (2018) Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome. Acta Cardiol 27:1–8
72.
Zurück zum Zitat Greene SJ, Felker GM, Giczewska A, Kalogeropoulos AP, Ambrosy AP, Chakraborty H, DeVore AD, Fudim M, McNulty SE, Mentz RJ, Vaduganathan M, Hernandez AF, Butler J (2019) Spironolactone in acute heart failure patients with renal dysfunction and risk factors for diuretic resistance: from the ATHENA-HF trial. Can J Cardiol. https://doi.org/10.1016/j.cjca.2019.01.022 Greene SJ, Felker GM, Giczewska A, Kalogeropoulos AP, Ambrosy AP, Chakraborty H, DeVore AD, Fudim M, McNulty SE, Mentz RJ, Vaduganathan M, Hernandez AF, Butler J (2019) Spironolactone in acute heart failure patients with renal dysfunction and risk factors for diuretic resistance: from the ATHENA-HF trial. Can J Cardiol. https://​doi.​org/​10.​1016/​j.​cjca.​2019.​01.​022
73.
Zurück zum Zitat Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39(Suppl 4):10–21 discussion 22PubMed Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39(Suppl 4):10–21 discussion 22PubMed
74.
Zurück zum Zitat Leithe ME, Margorien RD, Hermiller JB, Unverferth DV, Leier CV (1984) Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 69:57–64PubMed Leithe ME, Margorien RD, Hermiller JB, Unverferth DV, Leier CV (1984) Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 69:57–64PubMed
75.
Zurück zum Zitat Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL (2009) Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 98:121–129PubMed Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL (2009) Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 98:121–129PubMed
76.
Zurück zum Zitat Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582–588PubMed Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582–588PubMed
77.
Zurück zum Zitat Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ (2010) CIBIS-2 Investigators and Committees. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12:974–982PubMed Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ (2010) CIBIS-2 Investigators and Committees. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12:974–982PubMed
78.
Zurück zum Zitat Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 34:1424–1431PubMed Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 34:1424–1431PubMed
79.
Zurück zum Zitat Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, van Heerebeek L, Hillege HL, Lam CS, Navis G, Voors AA (2016) Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18:588–598PubMed Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, van Heerebeek L, Hillege HL, Lam CS, Navis G, Voors AA (2016) Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18:588–598PubMed
80.
Zurück zum Zitat Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271PubMed Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271PubMed
81.
Zurück zum Zitat Valente MA, Hillege HL, Navis G, Voors AA, Dunselman PH, van Veldhuisen DJ, Damman K (2014) The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail 16:86–94PubMed Valente MA, Hillege HL, Navis G, Voors AA, Dunselman PH, van Veldhuisen DJ, Damman K (2014) The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail 16:86–94PubMed
82.
Zurück zum Zitat Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ, CHARM Investigators and Committees. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543–550 Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ, CHARM Investigators and Committees. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543–550
83.
Zurück zum Zitat Brisco MA, Zile MR, Ter Maaten JM, Hanberg JS, Wilson FP, Parikh C, Testani JM (2016) The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio. Int J Cardiol 215:521–526PubMedPubMedCentral Brisco MA, Zile MR, Ter Maaten JM, Hanberg JS, Wilson FP, Parikh C, Testani JM (2016) The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio. Int J Cardiol 215:521–526PubMedPubMedCentral
84.
Zurück zum Zitat Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, van Veldhuisen DJ, Montagna L, Cosmi F, Tognoni G, Tavazzi L, Latini R (2011) Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32:2705–2712PubMed Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, van Veldhuisen DJ, Montagna L, Cosmi F, Tognoni G, Tavazzi L, Latini R (2011) Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32:2705–2712PubMed
85.
Zurück zum Zitat Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R (2013) Tubular damage and worsening renal function in chronic heart failure. JACC Heart Fail 1:417–424PubMed Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R (2013) Tubular damage and worsening renal function in chronic heart failure. JACC Heart Fail 1:417–424PubMed
86.
Zurück zum Zitat Damman K, Ng Kam Chuen MJ, MacFadyen RJ, Lip GY, Gaze D, Collinson PO, Hillege HL, van Oeveren W, Voors AA, van Veldhuisen DJ (2011) Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 57:2233–2241PubMed Damman K, Ng Kam Chuen MJ, MacFadyen RJ, Lip GY, Gaze D, Collinson PO, Hillege HL, van Oeveren W, Voors AA, van Veldhuisen DJ (2011) Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 57:2233–2241PubMed
87.
Zurück zum Zitat Matsue Y, Ter Maaten JM, Struck J, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, van Veldhuisen DJ, van der Meer P, Damman K, Voors AA (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. J Card Fail 23:231–239PubMed Matsue Y, Ter Maaten JM, Struck J, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, van Veldhuisen DJ, van der Meer P, Damman K, Voors AA (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. J Card Fail 23:231–239PubMed
88.
Zurück zum Zitat Ng LL, Squire IB, Jones DJL, Cao TH, Chan DCS, Sandhu JK, Quinn PA, Davies JE, Struck J, Hartmann O, Bergmann A, Mebazaa A, Gayat E, Arrigo M, Akiyama E, Sabti Z, Lohrmann J, Twerenbold R, Herrmann T, Schumacher C, Kozhuharov N, Mueller C, Network GREAT (2017) Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT Network study. J Am Coll Cardiol 69:56–69PubMed Ng LL, Squire IB, Jones DJL, Cao TH, Chan DCS, Sandhu JK, Quinn PA, Davies JE, Struck J, Hartmann O, Bergmann A, Mebazaa A, Gayat E, Arrigo M, Akiyama E, Sabti Z, Lohrmann J, Twerenbold R, Herrmann T, Schumacher C, Kozhuharov N, Mueller C, Network GREAT (2017) Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT Network study. J Am Coll Cardiol 69:56–69PubMed
89.
Zurück zum Zitat Martens P, Dupont M, Verbrugge FH, Damman K, Degryse N, Nijst P, Reynders C, Penders J, Tang WHW, Testani J, Mullens W (2019) Urinary sodium profiling in chronic heart failure to detect development of acute decompensated heart failure. JACC Heart Fail. 7:404–414PubMed Martens P, Dupont M, Verbrugge FH, Damman K, Degryse N, Nijst P, Reynders C, Penders J, Tang WHW, Testani J, Mullens W (2019) Urinary sodium profiling in chronic heart failure to detect development of acute decompensated heart failure. JACC Heart Fail. 7:404–414PubMed
90.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members, Document Reviewers (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975PubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members, Document Reviewers (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975PubMed
91.
Zurück zum Zitat Damman K, Tang WH, Felker GM, Lassus J, Zannad F, Krum H, McMurray JJ (2014) Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. J Am Coll Cardiol 63:853–871PubMed Damman K, Tang WH, Felker GM, Lassus J, Zannad F, Krum H, McMurray JJ (2014) Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. J Am Coll Cardiol 63:853–871PubMed
92.
Zurück zum Zitat Ghali JK, Wikstrand J, van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H (2009) The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). J Card Fail 15:310–318PubMed Ghali JK, Wikstrand J, van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H (2009) The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). J Card Fail 15:310–318PubMed
93.
Zurück zum Zitat Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, EMPHASIS-HF Study Group (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21PubMed Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, EMPHASIS-HF Study Group (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21PubMed
94.
Zurück zum Zitat Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD, RALES Investigators (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol 60:2082–2089PubMed Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD, RALES Investigators (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol 60:2082–2089PubMed
95.
Zurück zum Zitat Ferreira JP, Abreu P, McMurray JJV, van Veldhuisen DJ, Swedberg K, Pocock SJ, Vincent J, Lins K, Rossignol P, Pitt B, Zannad F (2019) Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial. Eur J Heart Fail 21:345–351PubMed Ferreira JP, Abreu P, McMurray JJV, van Veldhuisen DJ, Swedberg K, Pocock SJ, Vincent J, Lins K, Rossignol P, Pitt B, Zannad F (2019) Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial. Eur J Heart Fail 21:345–351PubMed
96.
Zurück zum Zitat Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV (2018) Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC Heart Fail 6:489–498PubMed Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV (2018) Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC Heart Fail 6:489–498PubMed
97.
Zurück zum Zitat Van Bommel RJ, Mollema SA, Borleffs CJ, Bertini M, Ypenburg C, Marsan NA, Delgado V, Van Der Wall EE, Schalij MJ, Bax JJ (2011) Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 57:549–555PubMed Van Bommel RJ, Mollema SA, Borleffs CJ, Bertini M, Ypenburg C, Marsan NA, Delgado V, Van Der Wall EE, Schalij MJ, Bax JJ (2011) Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 57:549–555PubMed
98.
Zurück zum Zitat Hoke U, Khidir MJ, van der Velde ET, Schalij MJ, Bax JJ, Delgado V, Marsan NA (2015) Cardiac resynchronization therapy in CKD stage 4 patients. Clin J Am Soc Nephrol 10:1740–1748PubMedPubMedCentral Hoke U, Khidir MJ, van der Velde ET, Schalij MJ, Bax JJ, Delgado V, Marsan NA (2015) Cardiac resynchronization therapy in CKD stage 4 patients. Clin J Am Soc Nephrol 10:1740–1748PubMedPubMedCentral
99.
Zurück zum Zitat Martens P, Verbrugge FH, Boonen L, Nijst P, Dupont M, Mullens W (2018) Value of routine investigations to predict loop diuretic down-titration success in stable heart failure. Int J Cardiol 250:171–175PubMed Martens P, Verbrugge FH, Boonen L, Nijst P, Dupont M, Mullens W (2018) Value of routine investigations to predict loop diuretic down-titration success in stable heart failure. Int J Cardiol 250:171–175PubMed
100.
Zurück zum Zitat Voors AA, Gori M, Liu LC, Claggett B, Zile MR, Pieske B, McMurray JJ, Packer M, Shi V, Lefkowitz MP, Solomon SD, Investigators PARAMOUNT (2015) Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 17:510–517PubMed Voors AA, Gori M, Liu LC, Claggett B, Zile MR, Pieske B, McMurray JJ, Packer M, Shi V, Lefkowitz MP, Solomon SD, Investigators PARAMOUNT (2015) Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 17:510–517PubMed
Metadaten
Titel
The role of the kidney in acute and chronic heart failure
verfasst von
Gaetano Ruocco
Alberto Palazzuoli
Jozine M. ter Maaten
Publikationsdatum
08.11.2019
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 1/2020
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-019-09870-6

Weitere Artikel der Ausgabe 1/2020

Heart Failure Reviews 1/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.